Listed

HeartSciences Inc.: Form 10-Q for the period ended Jul 31, 2024

Filed with the SEC on Sep 12, 2024 and accepted by EDGAR at Sep 12, 2024, 16:09 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2024-07-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2024-05-01 to 2024-07-31$1.2mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2024-05-01 to 2024-07-31$850.7kus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2024-05-01 to 2024-07-31−$2.1mus-gaap:OperatingIncomeLoss
Interest expense3 months2024-05-01 to 2024-07-31$22.5kus-gaap:InterestExpenseNonoperating
Net income3 months2024-05-01 to 2024-07-31−$2.1mus-gaap:NetIncomeLoss
Diluted EPS3 months2024-05-01 to 2024-07-31−$2.64us-gaap:EarningsPerShareDiluted
Basic EPS3 months2024-05-01 to 2024-07-31−$2.64us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2024-05-01 to 2024-07-31777,746 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2024-05-01 to 2024-07-31−$2.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2024-07-31$4.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2024-07-31$6.1mus-gaap:AssetsCurrent
Total assetsAt period end2024-07-31$8.2mus-gaap:Assets
Current liabilitiesAt period end2024-07-31$1.4mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2024-07-31$2.3mus-gaap:Liabilities
Shareholders' equityAt period end2024-07-31$5.9mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000950170-24-105914. Last ingested by Listed: Nov 4, 2026, 19:48 ET. Listed shows no prices and gives no investment advice.